Taniguchi T - Search Results

1

Quantitative analysis of vascular endothelial growth factor in primary breast cancer.

Toi M, Kondo S, Suzuki H, Yamamoto Y, Inada K, Imazawa T, Taniguchi T, Tominaga T. Toi M, et al. Among authors: taniguchi t. Cancer. 1996 Mar 15;77(6):1101-6. doi: 10.1002/(sici)1097-0142(19960315)77:6<1101::aid-cncr15>3.0.co;2-5. Cancer. 1996. PMID: 8635130

2

Serum concentrations of hepatocyte growth factor in breast cancer patients.

Taniguchi T, Toi M, Inada K, Imazawa T, Yamamoto Y, Tominaga T. Taniguchi T, et al. Clin Cancer Res. 1995 Sep;1(9):1031-4. Clin Cancer Res. 1995. PMID: 9816076

3

Concentrations of vascular endothelial growth factor in the sera of normal controls and cancer patients.

Yamamoto Y, Toi M, Kondo S, Matsumoto T, Suzuki H, Kitamura M, Tsuruta K, Taniguchi T, Okamoto A, Mori T, Yoshida M, Ikeda T, Tominaga T. Yamamoto Y, et al. Among authors: taniguchi t. Clin Cancer Res. 1996 May;2(5):821-6. Clin Cancer Res. 1996. PMID: 9816236

4

Increase in the circulating level of hepatocyte growth-factor in breast-cancer patients with distant metastases.

Taniguchi T, Toi M, Tominaga T. Taniguchi T, et al. Oncol Rep. 1994 Nov;1(6):1199-201. doi: 10.3892/or.1.6.1199. Oncol Rep. 1994. PMID: 21607515

5

Regulation of endothelial growth factor expressions in breast cancer.

Toi M, Yamamoto Y, Taniguchi T, Saji S, Hayashi K, Tominaga T. Toi M, et al. Among authors: taniguchi t. Gan To Kagaku Ryoho. 1996 Mar;23 Suppl 1:75-9. Gan To Kagaku Ryoho. 1996. PMID: 8702315

6

Increase in the circulating level of hepatocyte growth factor in gastric cancer patients.

Taniguchi T, Kitamura M, Arai K, Iwasaki Y, Yamamoto Y, Igari A, Toi M. Taniguchi T, et al. Br J Cancer. 1997;75(5):673-7. doi: 10.1038/bjc.1997.120. Br J Cancer. 1997. PMID: 9043023 Free PMC article.

7

Clinical significance of the determination of angiogenic factors.

Toi M, Taniguchi T, Yamamoto Y, Kurisaki T, Suzuki H, Tominaga T. Toi M, et al. Among authors: taniguchi t. Eur J Cancer. 1996 Dec;32A(14):2513-9. doi: 10.1016/s0959-8049(96)00397-8. Eur J Cancer. 1996. PMID: 9059341 Review. No abstract available.

8

Significance of circulating hepatocyte growth factor level as a prognostic indicator in primary breast cancer.

Toi M, Taniguchi T, Ueno T, Asano M, Funata N, Sekiguchi K, Iwanari H, Tominaga T. Toi M, et al. Among authors: taniguchi t. Clin Cancer Res. 1998 Mar;4(3):659-64. Clin Cancer Res. 1998. PMID: 9533534

9

Expression of platelet-derived endothelial cell growth factor/thymidine phosphorylase in human breast cancer.

Toi M, Hoshina S, Taniguchi T, Yamamoto Y, Ishitsuka H, Tominaga T. Toi M, et al. Among authors: taniguchi t. Int J Cancer. 1995 Apr 21;64(2):79-82. doi: 10.1002/ijc.2910640202. Int J Cancer. 1995. PMID: 7542228

10

[The effect of combination treatment consisted of 5'-deoxy-5-fluorouridine and medroxyprogesterone acetate for recurrent breast cancer patient].

Toi M, Taniguchi T, Hayashi K, Tominaga T. Toi M, et al. Among authors: taniguchi t. Gan To Kagaku Ryoho. 1995 May;22(6):799-804. Gan To Kagaku Ryoho. 1995. PMID: 7755388 Clinical Trial. Japanese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,599 results

Search Page

Filters